The Evaluation Value of 18F-FDG PET/CT Combined with Serum FGFR4 and CA19-9 for the Efficacy of Neoadjuvant Chemotherapy in Non-small Cell Lung Carcinoma Patients

SONG Yan, FU Wei, ZHANG Jie

PDF(1164 KB)
Welcome to Labeled Immunoassays and Clinical Medicine website!
PDF(1164 KB)
Labeled Immunoassays and Clinical Medicine ›› 2025, Vol. 32 ›› Issue (3) : 568-573. DOI: 10.11748/bjmy.issn.1006-1703.2025.03.022
Clinical Investigation

The Evaluation Value of 18F-FDG PET/CT Combined with Serum FGFR4 and CA19-9 for the Efficacy of Neoadjuvant Chemotherapy in Non-small Cell Lung Carcinoma Patients

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2025, 32(3): 568-573 https://doi.org/10.11748/bjmy.issn.1006-1703.2025.03.022

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1164 KB)

Accesses

Citation

Detail
Sections
Recommended
京ICP备18063657号-2
Copyright © Labeled Immunoassays and Clinical Medicine, All Rights Reserved.
Tel: 010-68515701,68517801　E-mail: bjmy@circ.com.cn

/

〈 〉